The report "Next-Generation Sequencing Services Market by Type (Targeted, RNA-Seq, Exome, De Novo), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Forecasts to 2022", [157 Pages Report] The global next generation sequencing services market is projected to reach USD 2,748.6 Million by 2022 from USD 868.1 Million in 2016, growing at a CAGR of 21.0% during 2017-2022.
Factors such as factors such as the declining price of sequencing; the high cost of sequencing infrastructure and the need for skilled professionals for efficient NGS sample preparation and analysis; and technological advancements in the field of sequencing are driving the growth of this market. Sequencing services are also the preferred option for NGS applications with low throughput requirements, which is another major driver for market growth.
Factors such as factors such as the declining price of sequencing; the high cost of sequencing infrastructure and the need for skilled professionals for efficient NGS sample preparation and analysis; and technological advancements in the field of sequencing are driving the growth of this market. Sequencing services are also the preferred option for NGS applications with low throughput requirements, which is another major driver for market growth.
Key Players in Market for Next-Generation Sequencing (NGS) Services
BGI (China), Eurofins Scientific SE (Luxembourg), PerkinElmer, Inc. (U.S.), Macrogen Inc. (South Korea), GENEWIZ, Inc. (U.S.), Illumina, Inc. (U.S.), QIAGEN (Germany), Novogene Corporation (China), and GATC Biotech AG (Germany)
Download PDF Sample Pages of Varicose Vein Treatment Market @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194102241
Years considered for the study
Historical Year - 2015
Base Year – 2016
Estimated Year - 2017
Forecast Period – 2017 – 2022
Scope of the Report
This research report categorizes the hybrid operating room market into the following segments and subsegments:
By Type
By Application
Objectives of the study are:
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales@marketsandmarkets.com
BGI (China), Eurofins Scientific SE (Luxembourg), PerkinElmer, Inc. (U.S.), Macrogen Inc. (South Korea), GENEWIZ, Inc. (U.S.), Illumina, Inc. (U.S.), QIAGEN (Germany), Novogene Corporation (China), and GATC Biotech AG (Germany)
Download PDF Sample Pages of Varicose Vein Treatment Market @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194102241
Years considered for the study
Historical Year - 2015
Base Year – 2016
Estimated Year - 2017
Forecast Period – 2017 – 2022
Scope of the Report
This research report categorizes the hybrid operating room market into the following segments and subsegments:
By Type
- Targeted Sequencing/Gene Panels
- RNA-Seq
- De Novo Sequencing
- Exome Sequencing
- CHiP-Seq
- Whole-genome Sequencing
- Methyl-Seq
- Other Services
- Sequencing by Synthesis (SBS)
- Ion Semiconductor Sequencing
- Single-Molecule Real-time (SMRT) Sequencing
- Nanopore Sequencing
By Application
- Diagnostics
- Drug Discovery
- Biomarker Discovery
- Microbial Genetics, Agriculture, and Animal Research
- Other Applications (Marine Research, Research in Biofuels, Forensic Medicine, Food Safety, and Phylogeographic & Phylogenetic Studies)
- Academic & Government Institutes and Research Centers
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Other End Users (NPOs, Agrigenomics Organizations, and Consumer Genomic Companies)
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Objectives of the study are:
- To define, describe, and forecast the next-generation sequencing (NGS) services market by type, technology, application, end user, and region
- To provide detailed information regarding factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges) along with current trends
- To analyze micromarkets with respect to their growth trends, prospects, and contributions to the total market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the revenue of the market segments with respect to four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World
- To profile the key players and comprehensively analyze their market shares and core competencies
- To track and analyze competitive developments such as product launches; agreements, partnerships, and collaborations; mergers & acquisitions; and research & development activities in the NGS services market
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales@marketsandmarkets.com
Comments
Post a Comment